Department of Pediatric Research, Oslo University Hospital
Title in Norwegian: PhD Position
Three-year fully funded PhD position at Department of Pediatric Research, Oslo University Hospital, investigating neonatal cholestasis mechanisms using induced pluripotent stem cell-derived liver organoids. Candidates must hold a master's degree in medicine, biomedicine, biotechnology or molecular biology, with practical skills in nucleic acid and protein analysis (qRT-PCR, Western blotting). Experience in cell cultivation, CRISPR/Cas9 gene editing, and scientific communication is advantageous.
Translated with AI. The Norwegian ad is the one that applies.
3-year 100% PhD position is available at the Department of Pediatric Research, OUS Rikshospitalet for a highly motivated and skilled PhD student on a project funded by South-Eastern Norway Regional Health Authority. The position is available from 23rd November 2026.
Neonatal cholestasis is a condition with impaired bile flow causing accumulation of bile acids and bilirubin, liver damage and debilitating pruritus. Reduction in bile to the intestine results in malabsorption, reduced weight gain, vitamin deficiency and changes in microbiota. Both genetic and environmental factors can result in cholestasis.
About the Department / Research Group
Professor Runar Almaas (Pediatric hepatology) at PFI, OUS is leading the project. The PhD candidate will be supervised by him and by Co-supervisor Barbora Smolkova (PhD) and senior researcher Gareth Sullivan. The group is using induced pluripotent stem cells for making liver organoids and a major part of the work will be related to this model.
What Tasks and Responsibilities Are Associated with the Position?
To reveal mechanisms of cholestasis and pruritus and to investigate novel potential treatments we are using liver organoids derived from disease-specific induced pluripotent stem cells. iPSC-derived liver organoids are a unique model that can mimic key features of the human liver and can be used to study liver development and disease. In these project liver organoids will be used for studying protein trafficking, effect of modulating factors and potential drugs.
experience in other relevant molecular biology techniques including gene editing using CRISPR/Cas9 technology, next-generation sequencing, etc is an advantage
Practical Information
We request that relevant documentation be attached to the application. Please note that all documents should be in English or a Scandinavian language.
Runar Almaas, Head of Department, +4741321932
Sognsvannsveien 20
0372 Oslo
Arbeidsgiver: Oslo universitetssykehus HF
Referansenr.: 5194655530
Stillingsprosent: 100%
Contract
Startdato: 23.11.2026
Sluttdato: 09.11.2029
Søknadsfrist: 15.11.2026
The application deadline is 15 November 2026.
The job is in Oslo.
They ask for a master's degree. This was read from the ad with AI and may be wrong. The ad is what counts.
They want you to have some experience, 1 to 3 years. This was read from the ad with AI and may be wrong. The ad is what counts.
Press “Apply for the job”. It takes you to the application at Department of Pediatric Research, Oslo University Hospital.
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments, and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel.
Apply by · 11 days until the deadline
Free, no account needed: see the requirements in the ad and which of them your CV covers.
Runar Almaas
Head of Department
+47 413 21 932Save the search and we tell you by e-mail when new jobs come in.
Set up a job alertThis was read from the ad with AI and may be wrong. The ad is what counts.